A detailed history of Moors & Cabot, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Moors & Cabot, Inc. holds 26,245 shares of BSX stock, worth $2.59 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
26,245
Previous 26,543 1.12%
Holding current value
$2.59 Million
Previous $2.04 Million 7.58%
% of portfolio
0.11%
Previous 0.11%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$72.96 - $84.0 $21,742 - $25,032
-298 Reduced 1.12%
26,245 $2.2 Million
Q2 2024

Aug 09, 2024

SELL
$67.33 - $77.71 $11,782 - $13,599
-175 Reduced 0.65%
26,543 $2.04 Million
Q1 2024

May 08, 2024

SELL
$57.6 - $68.62 $224,179 - $267,069
-3,892 Reduced 12.71%
26,718 $1.83 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $92,853 - $110,359
1,909 Added 6.65%
30,610 $1.77 Million
Q3 2023

Nov 07, 2023

SELL
$50.19 - $54.68 $12,196 - $13,287
-243 Reduced 0.84%
28,701 $1.52 Million
Q2 2023

Aug 09, 2023

SELL
$49.72 - $54.64 $78,309 - $86,058
-1,575 Reduced 5.16%
28,944 $1.57 Million
Q1 2023

May 04, 2023

SELL
$45.09 - $50.03 $73,090 - $81,098
-1,621 Reduced 5.04%
30,519 $1.53 Million
Q4 2022

Feb 09, 2023

BUY
$39.56 - $47.22 $356 - $424
9 Added 0.03%
32,140 $1.49 Million
Q4 2022

Feb 06, 2023

SELL
$39.56 - $47.22 $30,738 - $36,689
-777 Reduced 2.36%
32,131 $1.49 Million
Q3 2022

Nov 07, 2022

SELL
$36.71 - $109.66 $94,344 - $281,826
-2,570 Reduced 7.24%
32,908 $1.28 Million
Q2 2022

Aug 08, 2022

BUY
$35.24 - $47.1 $105,367 - $140,829
2,990 Added 9.2%
35,478 $1.32 Million
Q1 2022

May 13, 2022

SELL
$40.9 - $45.1 $130,593 - $144,004
-3,193 Reduced 8.95%
32,488 $1.44 Million
Q4 2021

Feb 14, 2022

BUY
$38.07 - $44.87 $49,491 - $58,331
1,300 Added 3.78%
35,681 $1.52 Million
Q3 2021

Dec 08, 2021

SELL
$41.23 - $45.88 $15.6 Million - $17.4 Million
-378,211 Reduced 91.67%
34,381 $1.5 Million
Q3 2021

Nov 05, 2021

BUY
$41.23 - $45.88 $15.6 Million - $17.4 Million
378,979 Added 1127.48%
412,592 $14 Million
Q2 2021

Aug 10, 2021

BUY
$38.58 - $44.24 $9,645 - $11,060
250 Added 0.75%
33,613 $1.44 Million
Q1 2021

May 12, 2021

BUY
$35.27 - $39.67 $59,959 - $67,439
1,700 Added 5.37%
33,363 $1.29 Million
Q4 2020

Feb 11, 2021

BUY
$33.15 - $41.97 $53,636 - $67,907
1,618 Added 5.39%
31,663 $1.14 Million
Q3 2020

Nov 09, 2020

SELL
$34.44 - $42.23 $102,872 - $126,141
-2,987 Reduced 9.04%
30,045 $1.15 Million
Q2 2020

Aug 13, 2020

BUY
$30.19 - $39.11 $376,680 - $487,975
12,477 Added 60.7%
33,032 $1.17 Million
Q1 2020

May 12, 2020

SELL
$25.83 - $45.71 $277,672 - $491,382
-10,750 Reduced 34.34%
20,555 $674,000
Q4 2019

Jan 28, 2020

BUY
$37.87 - $45.37 $2,840 - $3,402
75 Added 0.24%
31,305 $1.42 Million
Q3 2019

Oct 22, 2019

SELL
$40.31 - $43.45 $11,367 - $12,252
-282 Reduced 0.89%
31,230 $1.26 Million
Q2 2019

Jul 18, 2019

SELL
$34.91 - $42.98 $96,246 - $118,495
-2,757 Reduced 8.05%
31,512 $1.36 Million
Q1 2019

May 06, 2019

SELL
$32.91 - $40.75 $1.13 Million - $1.4 Million
-34,269 Reduced 50.0%
34,269 $1.32 Million
Q1 2019

May 01, 2019

BUY
$32.91 - $40.75 $882,448 - $1.09 Million
26,814 Added 64.27%
68,538 $2.64 Million
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $40,455 - $49,776
1,275 Added 3.15%
41,724 $1.48 Million
Q3 2018

Nov 14, 2018

SELL
$32.83 - $38.63 $99,179 - $116,701
-3,021 Reduced 6.95%
40,449 $1.57 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $166,354 - $212,715
-6,198 Reduced 12.48%
43,470 $1.43 Million
Q1 2018

May 18, 2018

SELL
$25.2 - $28.54 $8,820 - $9,989
-350 Reduced 0.7%
49,668 $1.36 Million
Q4 2017

Feb 13, 2018

BUY
$24.79 - $29.8 $1,065 - $1,281
43 Added 0.09%
50,018 $1.24 Million
Q3 2017

Nov 16, 2017

BUY
$26.26 - $29.17 $47,268 - $52,506
1,800 Added 3.74%
49,975 $1.47 Million
Q2 2017

Aug 15, 2017

BUY
N/A
48,175
48,175 $1.35 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $141B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Moors & Cabot, Inc. Portfolio

Follow Moors & Cabot, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.